Clobetasol propionate
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
129 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Psoriasis | D011565 | EFO_0000676 | L40 | 10 | 9 | 8 | 16 | 4 | 46 |
| Lichen sclerosus et atrophicus | D018459 | — | L90.0 | — | 5 | 4 | 1 | 5 | 14 |
| Vulvar lichen sclerosus | D007724 | — | N90.4 | — | 5 | 3 | 1 | 4 | 12 |
| Dermatitis | D003872 | HP_0011123 | L30.9 | 4 | 2 | 1 | 3 | 2 | 11 |
| Bullous pemphigoid | D010391 | EFO_0007187 | L12 | — | 2 | 1 | 2 | 1 | 6 |
| Alopecia areata | D000506 | EFO_0004192 | L63 | 1 | — | 1 | 3 | — | 5 |
| Alopecia | D000505 | HP_0002293 | L64 | 1 | — | 1 | 3 | — | 5 |
| Contact dermatitis | D003877 | — | L25 | 1 | — | — | 1 | — | 2 |
| Skin diseases | D012871 | — | L00-L99 | — | — | — | 1 | 1 | 2 |
| Occupational dermatitis | D009783 | — | — | — | — | — | 1 | — | 1 |
Show 6 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Lichen planus | D008010 | — | L43 | — | 7 | 3 | — | 3 | 11 |
| Oral lichen planus | D017676 | — | — | — | 6 | 2 | — | 3 | 10 |
| Inflammation | D007249 | MP_0001845 | — | — | — | 3 | — | 1 | 4 |
| Graft vs host disease | D006086 | — | D89.81 | — | 2 | 1 | — | — | 3 |
| Cataract | D002386 | HP_0000518 | H26.9 | — | — | 3 | — | — | 3 |
| Bronchiolitis obliterans syndrome | D000092122 | — | — | — | 1 | 1 | — | — | 2 |
| Oral manifestations | D009912 | — | — | — | — | 1 | — | — | 1 |
| Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | — | — | 1 | — | — | 1 |
| Arthritis | D001168 | HP_0001369 | M05-M14 | — | — | 1 | — | — | 1 |
| Seborrheic dermatitis | D012628 | HP_0001051 | L21 | — | — | 1 | — | — | 1 |
Show 2 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Atopic dermatitis | D003876 | EFO_0000274 | L20 | 3 | 2 | — | — | 1 | 5 |
| Eczema | D004485 | HP_0000964 | L30.9 | 2 | 2 | — | — | 1 | 4 |
| Atrophy | D001284 | — | — | 2 | 1 | — | — | — | 3 |
| Stevens-johnson syndrome | D013262 | EFO_0004276 | L51.1 | 2 | 1 | — | — | — | 2 |
| Granuloma | D006099 | — | — | — | 2 | — | — | — | 2 |
| Phlebitis | D010689 | EFO_1001395 | I80 | 1 | 1 | — | — | — | 1 |
| Herpes simplex | D006561 | — | B00 | — | 1 | — | — | — | 1 |
| Herpes labialis | D006560 | EFO_1001347 | B00.1 | — | 1 | — | — | — | 1 |
| Renal cell carcinoma | D002292 | EFO_0000376 | — | — | 1 | — | — | — | 1 |
| Colorectal neoplasms | D015179 | — | — | — | 1 | — | — | — | 1 |
Show 3 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 4 | — | — | — | 3 | 7 |
| Connective tissue diseases | D003240 | EFO_1001986 | M35 | 2 | — | — | — | — | 2 |
| Skin and connective tissue diseases | D017437 | — | — | 2 | — | — | — | — | 2 |
| Vasoconstriction | D014661 | — | — | 1 | — | — | — | — | 1 |
| Systemic scleroderma | D012595 | EFO_0000717 | M34.0 | 1 | — | — | — | — | 1 |
| Localized scleroderma | D012594 | EFO_1001361 | L94.0 | 1 | — | — | — | — | 1 |
| Ulcer | D014456 | MPATH_579 | — | 1 | — | — | — | — | 1 |
| Oral ulcer | D019226 | HP_0000155 | — | 1 | — | — | — | — | 1 |
| Pilot projects | D010865 | — | — | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hyperpigmentation | D017495 | HP_0000953 | — | — | — | — | — | 2 | 2 |
| Eosinophilia | D004802 | HP_0001880 | D72.1 | — | — | — | — | 1 | 1 |
| Drug hypersensitivity syndrome | D063926 | EFO_1002004 | D72.12 | — | — | — | — | 1 | 1 |
| Low-level light therapy | D028022 | — | — | — | — | — | — | 1 | 1 |
| Lyme disease | D008193 | — | A69.2 | — | — | — | — | 1 | 1 |
| Precancerous conditions | D011230 | — | — | — | — | — | — | 1 | 1 |
| Lentigo | D007911 | — | L81.4 | — | — | — | — | 1 | 1 |
| Adrenal insufficiency | D000309 | — | — | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 4,521 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
7,852 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use